Vertex Pharmaceuticals (VRTX) Misses Q4 Earnings Estimates

Vertex Pharmaceuticals (VRTX) came out with quarterly earnings of $3.98 per share, missing the Zacks Consensus Estimate of$ 3.99 per share. This compares to earnings of $4.20 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -0.25%. A quarter ago, it was expected that this drugmaker would post earnings of$ 4.13 per share when it actually produced earnings of $4.38, delivering a surprise of 6.05%.Over the last four quarters, the ...